Cargando…
Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
Cancer causes the second-highest rate of death world-wide. A major shortcoming inherent in most of anticancer drugs is their lack of tumor selectivity. Nanodrugs for cancer therapy administered intravenously escape renal clearance, are unable to penetrate through tight endothelial junctions of norma...
Autores principales: | Subhan, Md Abdus, Yalamarty, Satya Siva Kishan, Filipczak, Nina, Parveen, Farzana, Torchilin, Vladimir P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234032/ https://www.ncbi.nlm.nih.gov/pubmed/34207137 http://dx.doi.org/10.3390/jpm11060571 |
Ejemplares similares
-
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
por: Subhan, Md Abdus, et al.
Publicado: (2023) -
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
por: Subhan, Md Abdus, et al.
Publicado: (2023) -
Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases
por: Filipczak, Nina, et al.
Publicado: (2021) -
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023) -
Lipid-Based Drug Delivery Systems in Regenerative Medicine
por: Filipczak, Nina, et al.
Publicado: (2021)